Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CCR5 | P51681 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7007006 | 1.00 | ALDH1A1 (0.32) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL6754271 | 0.84 | ALDH1A1 (0.33) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL5236422 | 0.84 | ALDH1A1 (0.33) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL7888777 | 0.82 | — | — | |
| SCHEMBL5230213 | 0.81 | PREP (0.37) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL9518867 | 0.76 | ALDH1A1 (0.34) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL9019973 | 0.76 | MAPT (0.37) | ALDH1A1MAPTHPGDCCR5NPC1 | |
| SCHEMBL7804783 | 0.76 | ALDH1A1 (0.38) | ALDH1A1MAPTHPGDCCR5TDP1 | |
| SCHEMBL5233422 | 0.75 | ALDH1A1 (0.40) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL9366344 | 0.75 | ALDH1A1 (0.40) | ALDH1A1MAPTHPGDCCR5RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1336612-B1 | NOVEL CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-6908913-B2 | Carbapenem derivatives | MEIJI SEIKI KAISHA, LTD. (JP) | 2005-06-21 | — | — | US | disclosed |
| US-20040038967-A1 | Novel carbapenem derivatives | MEIJI SEIKI KAISHA, LTD. (JP) | 2004-02-26 | — | — | US | disclosed |
| EP-1336612-A1 | NOVEL CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA LTD. (JP) | 2003-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038967-A1 | Novel carbapenem derivatives | DHPS, HAMP, MCRS1 | ALDH1A1 1076/4885MAPT 4499/4885HPGD 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.